Bill Commons

CA AB 634

in committee

Tianeptine.

California · 2025-2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did CA AB 634 pass?

Not yet. CA AB 634 is in committee and has not come to a final vote. Latest recorded action (2026-08-13): In committee: Held under submission.

What is CA AB 634 about?

Existing law provides for the regulation of various chemicals, including chemicals contained in drugs, dietary supplements, and food products. This bill would prohibit an entity, as defined, from manufacturing, distributing, or offering for sale in this state a product that contains tianeptine or that is marketed as containing tianeptine. The bill would make a violation of these provisions punishable by a civil penalty not to exceed $2,500 for a first violation and not to exceed $5,000 for each subsequent violation, upon an action brought by the Attorney General, a city attorney, or a county counsel. The bill would entitle a prevailing plaintiff to an award of reasonable attorney's fees and costs.

Who sponsors CA AB 634?

Jeff Gonzalez is the primary sponsor of CA AB 634, joined by 6 cosponsors.

Description

Existing law provides for the regulation of various chemicals, including chemicals contained in drugs, dietary supplements, and food products. This bill would prohibit an entity, as defined, from manufacturing, distributing, or offering for sale in this state a product that contains tianeptine or that is marketed as containing tianeptine. The bill would make a violation of these provisions punishable by a civil penalty not to exceed $2,500 for a first violation and not to exceed $5,000 for each subsequent violation, upon an action brought by the Attorney General, a city attorney, or a county counsel. The bill would entitle a prevailing plaintiff to an award of reasonable attorney's fees and costs.

Introduced
2026-01-05
Latest action
2026-08-13 — In committee: Held under submission.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Jeff Gonzalezauthor
  • Alaniscoauthor
  • Dixoncoauthor
  • Sanchezcoauthor
  • Choicoauthor
  • Jonescoauthor
  • Ochoa Boghcoauthor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-08-13

    In committee: Held under submission.

  2. 2026-08-03

    In committee: Referred to APPR. suspense file.

  3. 2026-06-24

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 13. Noes 0.) (June 23). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  4. 2026-06-18

    From committee: Do pass and re-refer to Com. on JUD. (Ayes 11. Noes 0.) (June 17). Re-referred to Com. on JUD.

    committee-passage,committee-passage-favorable,referral-committee

  5. 2026-06-08

    From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.

    amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee

  6. 2026-05-06

    Referred to Coms. on HEALTH and JUD.

    referral-committee

  7. 2026-01-29

    In Senate. Read first time. To Com. on RLS. for assignment.

    reading-1,referral-committee

  8. 2026-01-29

    Read third time. Passed. Ordered to the Senate. (Ayes 74. Noes 0. Page 3872.)

    passage,reading-1,reading-3

  9. 2026-01-22

    In committee: Set, first hearing. Referred to suspense file.

    referral-committee

  10. 2026-01-22

    Assembly Rule 63 suspended. (Page 3806.)

  11. 2026-01-22

    From committee: Do pass. (Ayes 15. Noes 0.) (January 22).

    committee-passage,committee-passage-favorable

  12. 2026-01-22

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  13. 2026-01-20

    Re-referred to Com. on APPR.

    referral-committee

  14. 2026-01-16

    Read second time and amended.

    amendment-passage,reading-1,reading-2

  15. 2026-01-15

    From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 12. Noes 0.) (January 15).

    amendment-introduction,amendment-passage,committee-passage,referral-committee

  16. 2026-01-13

    From committee: Do pass and re-refer to Com. on JUD. (Ayes 15. Noes 0.) (January 13). Re-referred to Com. on JUD.

    committee-passage,committee-passage-favorable,referral-committee

  17. 2026-01-08

    Assembly Rule 56 suspended. (Page 3717.)

  18. 2026-01-08

    (Pending re-refer to Com. on JUD.)

    referral-committee

  19. 2026-01-05

    Re-referred to Coms. on HEALTH and JUD. pursuant to Assembly Rule 96.

    referral-committee

  20. 2026-01-05

    From committee chair, with author's amendments: Amend, and re-refer to Com. on PUB. S. Read second time and amended.

    amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee

  21. 2026-01-05

    Re-referred to Com. on PUB. S.

    referral-committee

  22. 2025-04-29

    In committee: Set, first hearing. Hearing canceled at the request of author.

  23. 2025-03-03

    Referred to Com. on PUB. S.

    referral-committee

  24. 2025-02-14

    From printer. May be heard in committee March 16.

  25. 2025-02-13

    Read first time. To print.

    reading-1

Versions

  • 02/13/25 - Introduced — 2025-02-13Compare
  • 01/05/26 - Amended Assembly — 2026-01-05Compare
  • 01/16/26 - Amended Assembly — 2026-01-16Compare
  • 06/08/26 - Amended Senate — 2026-06-08Compare
  • AB634Compare
  • (document, no version)Compare

Documents

Votes

  • Do pass and be re-referred to the Committee on [Judiciary]

    2026-01-13 · pass · 15-0

    Member-level votes (16)
    • Bonta: yes
    • Mark González: yes
    • Patel: yes
    • Aguiar-Curry: yes
    • Schiavo: yes
    • Gallagher: yes
    • Krell: yes
    • Stefani: yes
    • Addis: yes
    • Sanchez: yes
    • Sharp-Collins: yes
    • Patterson: yes
    • Carrillo: yes
    • Chen: yes
    • Caloza: yes
    • Celeste Rodriguez: other

  • Do pass as amended and be re-referred to the Committee on [Appropriations]

    2026-01-15 · pass · 12-0

    Member-level votes (12)
    • Johnson: yes
    • Dixon: yes
    • Connolly: yes
    • Bauer-Kahan: yes
    • Papan: yes
    • Kalra: yes
    • Bryan: yes
    • Pacheco: yes
    • Zbur: yes
    • Harabedian: yes
    • Macedo: yes
    • Stefani: yes

  • Do pass.

    2026-01-22 · pass · 15-0

    Member-level votes (15)
    • Hoover: yes
    • Tangipa: yes
    • Bauer-Kahan: yes
    • Wicks: yes
    • Krell: yes
    • Pacheco: yes
    • Stefani: yes
    • Solache: yes
    • Pellerin: yes
    • Caloza: yes
    • Calderon: yes
    • Fong: yes
    • Mark González: yes
    • Ta: yes
    • Dixon: yes

  • AB 634 Jeff Gonzalez Assembly Third Reading

    2026-01-29 · pass · 74-0

    Member-level votes (80)
    • Sharp-Collins: yes
    • Ramos: yes
    • Schultz: yes
    • Ahrens: yes
    • Calderon: yes
    • Harabedian: yes
    • Carrillo: yes
    • Mark González: yes
    • Chen: yes
    • Michelle Rodriguez: yes
    • Pacheco: yes
    • Alvarez: yes
    • Bains: yes
    • Haney: yes
    • Patterson: yes
    • Sanchez: yes
    • Aguiar-Curry: yes
    • Berman: yes
    • Ta: yes
    • Solache: yes
    • Elhawary: yes
    • Muratsuchi: yes
    • Macedo: yes
    • Papan: yes
    • Gallagher: yes
    • Nguyen: yes
    • Bryan: yes
    • Boerner: yes
    • Bennett: yes
    • Tangipa: yes
    • Flora: yes
    • Fong: yes
    • Rivas: yes
    • Rogers: yes
    • Hadwick: yes
    • Jeff Gonzalez: yes
    • Ávila Farías: yes
    • Petrie-Norris: yes
    • Caloza: yes
    • Irwin: yes
    • Kalra: yes
    • Patel: yes
    • Pellerin: yes
    • Bauer-Kahan: yes
    • Bonta: yes
    • Blanca Rubio: yes
    • DeMaio: yes
    • Soria: yes
    • Lackey: yes
    • Hoover: yes
    • Ortega: yes
    • Wallis: yes
    • Johnson: yes
    • Gabriel: yes
    • Schiavo: yes
    • Castillo: yes
    • Krell: yes
    • Stefani: yes
    • Zbur: yes
    • Davies: yes
    • Wilson: yes
    • Addis: yes
    • Ward: yes
    • Garcia: yes
    • Connolly: yes
    • Dixon: yes
    • Quirk-Silva: yes
    • Wicks: yes
    • Lee: yes
    • Jackson: yes
    • Alanis: yes
    • Hart: yes
    • Ellis: yes
    • Lowenthal: yes
    • Arambula: other
    • McKinnor: other
    • Celeste Rodriguez: other
    • Ransom: other
    • Gipson: other
    • Valencia: other

  • Do pass, but first be re-referred to the Committee on [Judiciary]

    2026-06-17 · pass · 11-0

    Member-level votes (11)
    • Grove: yes
    • Gonzalez: yes
    • Menjivar: yes
    • Smallwood-Cuevas: yes
    • Padilla: yes
    • Caballero: yes
    • Valladares: yes
    • Weber Pierson: yes
    • Pérez: yes
    • Rubio: yes
    • Durazo: yes

  • Do pass, but first be re-referred to the Committee on [Appropriations]

    2026-06-23 · pass · 13-0

    Member-level votes (13)
    • Ashby: yes
    • Valladares: yes
    • Reyes: yes
    • Stern: yes
    • Caballero: yes
    • Laird: yes
    • Wahab: yes
    • Umberg: yes
    • Wiener: yes
    • Weber Pierson: yes
    • Durazo: yes
    • Allen: yes
    • Niello: yes

Related bills

No related bills recorded for this bill.

Official source

http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202520260AB634

Attribution

Data from openstates_api_sync, retrieved 2026-08-01T14:16:02.923288Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changesStatus and relationship changes

Session-wide evidence can include changes to other bills:

Bulk imports for this sessionSession dates and activity

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 634. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.